Aegon Ltd. · EURONEXT:AGN

Aegon — Shareholder Meeting (June 2026)

48 slides from Aegon's shareholder meeting presentation, Jun 10, 2026

  1. Slide 1: Welcome Annual General Meeting of Shareholders

    Filed by Aegon Ltd. Pursuant to Rule 425 under the Securities Act of 1933 Subject Company: Aegon Ltd. Commission File No. : 001-10882 Welcome Annual General Meeting of Shareholders Bermuda, June 10, 2026

  2. Slide 2: Disclaimer: Important Information for Investors and Securityholders

    Disclaimer Important Information for Investors and Securityholders This communication is not intended to and does not constitute an offer to sell, buy or exchange or the solicitation of an off er to sell, buy or exchange any securities or the solicitation of any vote or approval in any jurisdiction,

  3. Slide 3: David Herzog, Chair of the Board of Directors

    David Herzog Chair of the Board of Directors

  4. Slide 4: Agenda item: Opening

    Agenda item 1 Opening 4

  5. Slide 5: Annual Report and Annual Accounts 2025

    Annual Report and Agenda item 2 Annual Accounts 2025 5

  6. Slide 6: Business Overview 2025, redomiciliation update, Annual Accounts 2025

    Business Overview 2025, update on the redomiciliation Agenda items 2.1 and 2.2 process , and presentation of the Annual Accounts 2025 6

  7. Slide 7: Lard Friese, CEO

    Lard Friese CEO

  8. Slide 8: Welcome

    Welcome 8

  9. Slide 9: Transforming Aegon

    Transforming Aegon ▪ Solid 2025 results demonstrate strength of strategy and ability to deliver on ambitions ▪ Delivered or exceeded financial targets set at CMD 2023 ▪ Continued to return capital to shareholders through dividends and share buybacks ▪ Unlocking next chapter in Aegon’s transformation

  10. Slide 10: Delivering on commitments: financial targets for 2025

    Delivering on commitments Financial targets for 2025 (in EUR million) 1 Operating capital generation US Financial Assets capital employed US capital employed (in USD billion) (in USD billion) 5.6 9.1 1,460 8.6 7.9 1,287 1,280 3.9 45% 34% Financial Assets ✓ 62% 2.7 ✓ 66% Strategic Assets 55% 38% FY20

  11. Slide 11: Strong commercial momentum at Transamerica Americas

    Strong commercial momentum at Transamerica Americas Protection Solutions Distribution Savings & Investments WFG licensed agents New individual life sales Net deposits mid -sized plans (number in thousand) (in USD billion) (in USD million) 96 1.1 617 86 473 0.6 36 36 37 36 FY24 FY25 FY24 FY25 FY24 FY

  12. Slide 12: Commercial momentum in other units

    Commercial momentum in other units International Asset Management New life sales Third-party net deposits (in EUR million) (in EUR billion) 269 13.7 266 24 27 37 4.5 35 64 71 9.2 3.1 144 132 2.1 1.0 FY24 FY25 FY24 FY25 TLB and others Strategic Partnerships Spain & Portugal Global Platforms China Bra

  13. Slide 13: Our purpose guided our actions

    Our purpose guided our actions ▪ Supporting customers in making confident financial choices ▪ More focused and data -driven approach to sustainability ▪ External recognition for sustainability approach 13

  14. Slide 14: Our transformation journey since 2020

    Our transformation journey since 2020 Our vision: Increasing focus Leader in investment, Building foundations protection, and retirement Implementing strategy solutions 14 14

  15. Slide 15: Relocating to the US

    Relocating to the US ▪ Focusing on the large and growing US market for life, protection and retirement solutions ▪ Building a bigger, broader, and more profitable US life insurance and retirement industry leader The Next Frontier: to become a leading ▪ After the relocation, Aegon Ltd. will continue

  16. Slide 16: Timeline to complete the relocation

    Timeline to complete the relocation 4Q 2026 Aim for Jan. 1, 2028 Legal domicile & EGM for approval Transition of legal seat and group regulator 1 of relocation regulator ; Aegon becomes domestic issuer Feb. 2027 Aug. 2027 2H 2027 Aim for Jan. 1, 2028 Group Update on Update on CMD Renaming Aegon Ltd.

  17. Slide 17: Concluding remarks

    ▪ Continued strong progress on Aegon’s transformation ▪ Continued to deliver or outperform on our financial commitments Concluding remarks ▪ Ready for the next frontier ▪ Extraordinary General Meeting (EGM) in fourth quarter of 2026 17

  18. Slide 18: Thank you

    Thank you

  19. Slide 19: Extraordinary General Meeting of Shareholders: timeline and agenda items

    Extraordinary General Timeline and agenda Meeting of Shareholders items 19

  20. Slide 20: Path to the EGM redomiciliation vote – indicative timeline

    Path to the EGM redomiciliation vote – indicative timeline Multiple opportunities for engagement leading to the EGM Proposed governance framework and Transition to US domestic agreement with Vereniging Aegon on issuer subject to US GAAP EGM investor Investor engagement on 1 go-forward structure anno

  21. Slide 21: Business Overview 2025, redomiciliation update, Annual Accounts 2025

    Business Overview 2025 , update on the redomiciliation Agenda items 2.1 and 2.2 process, and presentation of the Annual Accounts 2025 21

  22. Slide 22: Agenda item 2.3 Remuneration Report 2025 – Advisory vote

    Agenda item 2.3 Remuneration Report 2025 Advisory vote 22

  23. Slide 23: Mark Ellman, Chair of the Compensation & Human Resource Committee

    Mark Ellman Chair of the Compensation & Human Resource Committee

  24. Slide 24: Remuneration Report content as published in the 2025 Integrated Annual Report

    Report content as published in the 2025 Integrated Annual Report ▪ Business and remuneration highlights 2025 Remuneration ▪ Remuneration at Aegon in general ▪ Remuneration Report regarding the Non - Report Executive Directors ▪ Remuneration Report regarding the Executive Director

  25. Slide 25: 2025 Non-Executive Director remuneration

    2025 Non-Executive Director remuneration 1 2 In EUR thousand Retainer cash Retainer shares Benefits Total 2025 Total 2024 As of June 12, 2025 81 28 109 David Herzog Chair as of November 13, 2025 Until November 12, 2025 William Connelly 325 108 433 500 Mark Ellman 130 30 160 153 Corien Wortmann 130 3

  26. Slide 26: CEO remuneration

    CEO remuneration 1 Allocated remuneration in 2025 In EUR 2 Salary STI Pension Benefits Total 2025 Total 2024 thousand 1,365 1,869 205 103 3,542 3,385 2025 Short -Term Incentive outcome Performance metrics Weight Target Result Score Operating Capital Generation 45% 1,187 1,287 142% Commercial metric

  27. Slide 27: CEO remuneration continued

    CEO remuneration continued 2026 Compensation package In EUR Target Total Salary Pension Target STI Target LTI thousand Compensation 221 1,472 3,685 1,474 6,854 15% 100% 250% Open cycle Long -Term Incentive Plans At target grant Value at grant date Holding LTI cycle (# of shares) (in EUR thousand) Ve

  28. Slide 28: Agenda item 2.3 Remuneration Report 2025 – Advisory vote

    Agenda item 2.3 Remuneration Report 2025 Advisory vote 28

  29. Slide 29: How to vote

    ▪ Please submit your vote by clicking on “for”, “against”, or “withheld” ▪ You can change your vote until the voting is closed ▪ A vote confirmation will be displayed Click here to vote How to vote 29

  30. Slide 30: Approval of the final dividend 2025

    Approval of the final dividend Agenda item 2.4 2025 Voting item 30

  31. Slide 31: Dividend

    Dividend ▪ It is proposed that the final dividend for 2025 will amount to EUR 0.21 per common share and EUR 0.00525 per common share B ▪ If approved, and in combination with the interim dividend paid over the first half of 2025, Aegon’s total dividend over 2025 will amount to EUR 0.40 per common sha

  32. Slide 32: Proposal to appoint EY as independent auditor for 2027

    Proposal to appoint Agenda item 3 .1 EY as independent auditor for the 2027 financial year Voting item 32

  33. Slide 33: Composition of the Board of Directors of Aegon

    Composition of the Board Agenda item 4 of Directors of Aegon Voting item 33

  34. Slide 34: Alteration of bye-law 21.2 and extension of Lard Friese's term

    Approval of alteration of bye-law 21.2 and extension of Mr. Lard Friese’s term as Executive Director (CEO) of the Agenda item 4.1 Board of Directors until the end of the AGM in 2030 Voting item 34

  35. Slide 35: Mr. Lard Friese

    Mr. Lard Friese ▪ Age: 63 ▪ Nationality: Dutch ▪ Main occupation: CEO and Chairman of the Executive Committee of Aegon Ltd. ▪ Shares in Aegon: 401,874 Memberships of other Boards: ▪ Chairman of the Board of Directors of the Geneva Association ▪ Member of the Supervisory Board of Pon Holdings B.V. (n

  36. Slide 36: Election of Ms. Leni Boeren as member of the Board

    Election of Ms. Leni Boeren as member of the Board of Agenda item 4.2 Directors until the end of the AGM in 2030 Voting item 36

  37. Slide 37: Ms. Leni Boeren

    Ms. Leni Boeren ▪ Age: 62 ▪ Nationality: Dutch ▪ Main occupation: Non -Executive Director ▪ Shares in Aegon: none Memberships of other Boards: ▪ Non-Executive member of the Board of Directors of Air France -KLM (listed) ▪ Member of the Supervisory Board of NIBC Bank ▪ Vice -Chair of the Supervisory

  38. Slide 38: Composition of the Board of Directors of Aegon

    Composition of the Board Agenda item 4 of Directors of Aegon Voting item 38

  39. Slide 39: Exclusion of pre-emptive rights and acquisition of shares

    Exclusion of pre -emptive Agenda item 5 rights and acquisition of shares Voting item 39

  40. Slide 40: Authorization to exclude pre-emptive rights: issuance under 10%

    Authorization of the Board of Directors to restrict or exclude pre-emptive rights in connection with an issuance of common shares of less than Agenda item 5.1 10% of the Company’s issued share capital Voting item 40

  41. Slide 41: Authorization to exclude pre-emptive rights: rights issue over 10%

    Authorization of the Board of Directors to restrict or exclude pre-emptive rights in connection with a rights issue in excess of 10% of the Agenda item 5.2 Company’s issued share capital Voting item 41

  42. Slide 42: Authorization to acquire shares in the Company

    Authorization of the Board of Agenda item 5.3 Directors to acquire shares in the Company Voting item 42

  43. Slide 43: Exclusion of pre-emptive rights and acquisition of shares

    Exclusion of pre -emptive Agenda item 5 rights and acquisition of shares Voting item 43

  44. Slide 44: Voting results

    Voting results ® aegon

  45. Slide 45: Agenda item: Any Other Business

    Agenda item 6 Any Other Business 45

  46. Slide 46: Agenda item: Closing

    Agenda item 7 Closing 46

  47. Slide 47: Thank you

    ® aegon Thank you

  48. Slide 48: End of Aegon's 2026 Annual General Meeting of Shareholders

    End of Aegon’s 2026 Annual General Meeting of Shareholders

Aegon — Shareholder Meeting (June 2026) on 6ix